Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Firefly Neuroscience Inc (AIFF)

Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,412
  • Shares Outstanding, K 7,945
  • Annual Sales, $ 7,980 K
  • Annual Income, $ -2,030 K
  • EBIT $ -6 M
  • EBITDA $ -6 M
  • 60-Month Beta 3.14
  • Price/Sales 56.85
  • Price/Cash Flow N/A
  • Price/Book 8.75

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.05 +13.44%
on 03/11/25
12.82 -73.01%
on 02/14/25
-12.00 (-77.62%)
since 02/13/25
3-Month
1.86 +86.02%
on 01/13/25
17.20 -79.88%
on 02/13/25
+0.33 (+10.54%)
since 12/13/24
52-Week
1.86 +86.02%
on 01/13/25
17.20 -79.88%
on 02/13/25
-5.00 (-59.10%)
since 03/13/24

Most Recent Stories

More News
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementiaCalgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix...

AIFF : 3.46 (+0.29%)
HMTXF : 0.0862 (+1.17%)
HEM.VN : 0.120 (unch)
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million

AIFF : 3.46 (+0.29%)
This Hidden-Gem Stock Is Skyrocketing on Nvidia News. Should You Buy It Now?

Firefly Neuroscience’s stock has skyrocketed over 200% in five days after joining Nvidia’s Partner Connect Program.

NVDA : 115.58 (-0.14%)
AIFF : 3.46 (+0.29%)
Firefly Neuroscience Leads Health Care Retail Follower Surge After Nvidia Connect Program Nod Sends Stock Soaring

The medtech firm plans to leverage these tools to build a human brain foundation model using its FDA-cleared Brain Network Analytics technology platform.

NVDA : 115.58 (-0.14%)
AIFF : 3.46 (+0.29%)
Firefly Perks on Hookup with Nvidia

Firefly Neuroscience, Inc. (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative ...

NVDA : 115.58 (-0.14%)
AIFF : 3.46 (+0.29%)
Firefly Neuroscience Accepted into NVIDIA Connect Program

AIFF : 3.46 (+0.29%)
Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

AIFF : 3.46 (+0.29%)
Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care

AIFF : 3.46 (+0.29%)
Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform

AIFF : 3.46 (+0.29%)
Firefly Neuroscience Closes on Financing of up to $12.4 Million

AIFF : 3.46 (+0.29%)

Business Summary

Firefly Neuroscience Inc. is an AI company developing neuroscientific solutions which improve outcomes for patients with mental illnesses and neurological disorders. Firefly Neuroscience Inc., formerly known as WaveDancer Inc., is based in TORONTO.

See More

Key Turning Points

3rd Resistance Point 3.90
2nd Resistance Point 3.74
1st Resistance Point 3.60
Last Price 3.46
1st Support Level 3.30
2nd Support Level 3.14
3rd Support Level 3.00

See More

52-Week High 17.20
Fibonacci 61.8% 11.34
Fibonacci 50% 9.53
Fibonacci 38.2% 7.72
Last Price 3.46
52-Week Low 1.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar